Please login to the form below

Not currently logged in
Email:
Password:

Pierre Fabre

This page shows the latest Pierre Fabre news and features for those working in and with pharma, biotech and healthcare.

A unique ecosystem

A unique ecosystem

Medicen has seen very positive results in 2016, with 20% business growth and the arrival of 80 new members, including mid-size pharma company Pierre Fabre.

Latest news

  • Cellectis appoints Dr Loan Hoang-Sayag as chief medical officer Cellectis appoints Dr Loan Hoang-Sayag as chief medical officer

    She has over 20 years of experience in haematology and medical oncology, and prior to Quintiles held positions at Pierre Fabre Oncology and Hoffman La Roche.

  • Cancer pain: opioids set to dominate Cancer pain: opioids set to dominate

    In clinical trials, dexmedetomidine was well tolerated. Pierre Fabre is developing befiradol, a selective serotonin-1A receptor agonist, for the treatment of chronic pain.

  • AZ and Redx collaborate on genetics of cancer AZ and Redx collaborate on genetics of cancer

    As for Redx, the company has interests in both oncology and in infectious diseases and has an existing cancer collaboration with Pierre Fabre Laboratories.

  • FDA approves AZ’s fish oil drug FDA approves AZ’s fish oil drug

    Omacor/Lovaza achieved end-user sales of around $1.4bn in 2011 and is sold by Abbott Laboratories in the US and various companies including GlaxoSmithKline, Grupo Ferrer and Pierre Fabre

  • This month in 2000: The formation of GSK This month in 2000: The formation of GSK

    As for who would lead the newly-formed GSK, it was a joint effort between the two constituent parts, with Jean-Pierre Garnier at the management helm as CEO of and ... After Garnier's departure to become CEO of Pierre Fabre Labs, the company's European

More from news
Approximately 1 fully matching, plus 17 partially matching documents found.

Latest Intelligence

  • A unique ecosystem A unique ecosystem

    Medicen has seen very positive results in 2016, with 20% business growth and the arrival of 80 new members, including mid-size pharma company Pierre Fabre.

  • Deal Watch November 2015 Deal Watch November 2015

    Acquisition - assets. Marketed global dermatology portfolio. 724. Array BioPharma. Pierre Fabre.

  • Investing in the future of R&D Investing in the future of R&D

    The bank, set up by the EU in 1958, has funded pharmaceutical activities before - Pierre Fabre and Ferrer Pharmaceutical are among the firms whose projects have been financed under its

  • Unravelling the complex patient journey: can it be done? Unravelling the complex patient journey: can it be done?

    Antoine has over ten years of new product launch and brand development experience in the pharmaceutical industry with roles at GSK, Novartis, Pierre Fabre Oncologie and Roche.

  • Country report: The healthcare market in France Country report: The healthcare market in France

    Evolution of the pharmaceutical market. Market dominance. The majority of drug research, development and production in France is carried out by the top five French players: Sanofi, Servier, Ipsen, Pierre Fabre

More from intelligence
Approximately 0 fully matching, plus 6 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 11 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
GCI Health

GCI Health London is a young, vibrant powerhouse in the European industry with a mission to redefine healthcare communications, starting...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics